Previous close | 22.09 |
Open | 22.02 |
Bid | 22.85 x 1000 |
Ask | 23.87 x 900 |
Day's range | 21.65 - 22.06 |
52-week range | 21.65 - 44.09 |
Volume | |
Avg. volume | 219,488 |
Market cap | 647.224M |
Beta (5Y monthly) | 1.45 |
PE ratio (TTM) | N/A |
EPS (TTM) | -5.63 |
Earnings date | 03 May 2024 - 07 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 26.67 |
Key Insights The projected fair value for Fulgent Genetics is US$33.29 based on 2 Stage Free Cash Flow to Equity...
Fulgent Genetics ( NASDAQ:FLGT ) Full Year 2023 Results Key Financial Results Revenue: US$289.2m (down 53% from FY...
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript February 28, 2024 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.3. Fulgent Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to […]